Company intelligence / Profile preview
Laboratorio Farmaceutico CT
- Ownership
- Private
- Employees
- ~82
- Development stage
- Commercial
Overview
Laboratorio Farmaceutico CT specializes in the development and manufacturing of generic pharmaceutical products as well as contract development for new drugs. The company has experience in central nervous system drug R&D, including alcohol addiction therapies targeting metabotropic glutamate receptor 5. It operates GMP-certified facilities capable of producing tablets, capsules, syrups, sterile ampoules/vials—including controlled substances—and supports both pilot-scale and full-scale manufacturing. No public clinical results are available.
- Therapeutic areas
- OtherRare DiseasesPsychiatryNeurology
- Modalities
- Small moleculePeptidesBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Laboratorio Farmaceutico CT.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorio Farmaceutico CT.